Beyond the skin lie disease mechanisms, the whole patient, and the future. Questions arising from patient care are carried into genetics, immunology, and oncology research—and returned to patients as better diagnosis and treatment.
About the DepartmentWe connect genetics, immunology and oncology to improve the future of every patient.
Genetic skin diseases, connective tissue diseases, and cutaneous oncology
Comprehensive evaluation and specialist treatment at a university hospital
A message from the Chair and our history since 1905
Translating clinical and basic research into patient care
Department visits are welcome throughout the year
Each team develops its expertise while sharing cases, methods, and knowledge across the department.
We conduct clinical and basic research on keratinization and epidermal differentiation disorders, autoinflammatory keratinization diseases, congenital hypotrichosis, and related conditions.
Learn More → 02CONNECTIVE TISSUE DISEASESBuilding on clinical care, we investigate autoantibodies, their target antigens, and disease biomarkers through clinical and basic research.
Learn More → 03CUTANEOUS ONCOLOGYWe provide surgery, systemic therapy, and comprehensive genomic profiling while advancing clinical studies, including multicenter research.
Learn More →The latest dermatology research announced through official Nagoya University press releases.
PACI-ON / ADIMAGE: NAGOYA UNIVERSITY PRESS RELEASEThe benefit remained evident at age three, especially for egg allergy.
Read the Press Release ↗
EDD / NOMENCLATUREIMAGE: NAGOYA UNIVERSITY PRESS RELEASEA gene-based classification replaces outdated disease terminology.
Read the Press Release ↗
PRP / CARD14IMAGE: NAGOYA UNIVERSITY PRESS RELEASESingle-cell analysis revealed part of the disease mechanism.
Read the Press Release ↗Recent peer-reviewed work published by members of our department.
PubMed-indexed records are checked automatically every 24 hours.
Horisaki K, et al. J Dermatol. 2026
A case series of 15 Japanese patients evaluated clinical outcomes of dacarbazine after failure of immune checkpoint inhibitors.
Miyazaki A, et al. Acta Derm Venereol. 2026
A retrospective cohort study found an association between low subcutaneous adipose tissue and poor prognosis in older patients with cutaneous angiosarcoma.
Fukuda R, et al. Acta Derm Venereol. 2026
A rare case of subcutaneous panniculitis-like T-cell lymphoma arising at widespread tattoo sites with secondary haemophagocytic lymphohistiocytosis was reported.
Meet the seven front-row faculty members through unified color illustrations, reflecting the people behind our clinical care, research, and education.
